Filing Flows

Filing Flows › Companies › Precigen › Cash flow

Precigen cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow$11.4M in Q3 2026 · −$74.3M over twelve months

Operating cash flow$11.9M
Capital spending−$435K
Free cash flow+$11.4M
Cash / net income0.3×

Analysis

In Q3 2026, Precigen generated $11.9M of operating cash flow and spent $435K on capital projects, leaving free cash flow of $11.4M. That is $40.9M more than in Q3 2025 (−$29.5M).

Over the twelve months to Sep 30, 2026, operating cash flow was −$73.2M; the largest uses were operating cash flow ($73.2M), taxes on employees’ shares ($1.7M), capital spending ($1.1M); besides operations, cash came from other investing ($74.7M), shares issued ($2.7M); the cash balance rose by $637K.

Operating cash flow was $11.9M against net income of $35.8M — 0.3× profit, less cash than reported earnings, worth checking against working capital. The largest differences: receivables −$24.6M, stock-based pay +$3.8M, inventory −$2.7M.

Free cash flow

Precigen: free cash flow by quarterPrecigen: free cash flow by quarter−$9.3MQ4 2024−$16.9MQ1 2025−$19.9MQ2 2025−$29.5MQ3 2025−$23.5MQ4 2025−$44.1MQ1 2026−$18.2MQ2 2026$11.4MQ3 2026
Operating cash flow less capital spending.
Precigen: operating cash flow against capital spendingPrecigen: operating cash flow against capital spendingOperating cash flowCapital spending−$8.2M$1.0MQ4 2024−$16.3M$622KQ1 2025−$19.0M$966KQ2 2025−$29.1M$389KQ3 2025−$23.5M$18KQ4 2025−$43.8M$258KQ1 2026−$17.8M$392KQ2 2026$11.9M$435KQ3 2026
Latest (Q3 2026): Operating cash flow $11.9M, Capital spending $435K.

Capital allocation, year by year

Precigen: where the cash came from (up) and went (down), by fiscal yearPrecigen: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingFY2021: Operating cash flow −$55.8MFY2021: Net borrowing −$466KFY2021: Capital spending −$7.2MFY2021FY2022: Operating cash flow −$65.0MFY2022: Net borrowing −$155MFY2022: Shares issued $1KFY2022: Asset sales $162MFY2022: Capital spending −$4.9M$162MFY2022FY2023: Operating cash flow −$66.9MFY2023: Net borrowing −$43.2MFY2023: Shares issued $72.8MFY2023: Capital spending −$1.5M$72.8MFY2023FY2024: Operating cash flow −$68.2MFY2024: Shares issued $111MFY2024: Capital spending −$8.6M$111MFY2024FY2025: Operating cash flow −$87.8MFY2025: Net borrowing $92.8MFY2025: Shares issued $310KFY2025: Capital spending −$2.0M$93.1MFY2025
Over these 5 years operating cash flow totalled −$344M; the largest uses were operating cash flow ($344M) and net borrowing ($199M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$46.1M
Debt$94.3M
Net debt$48.2M
Cash runway7 months

Precigen is burning cash: its operations consume cash, a free cash flow of −$74.3M a year at the current rate against $46.1M of cash and investments: a runway of about 7 months before any new financing.

Precigen: debt maturities by year (FY2025)Precigen: debt maturities by year (FY2025)$12.5MYear 3$50.0MYear 4$37.5MYear 5
Principal due in each year as disclosed in the annual report, against $46.1M of cash and investments now.

Where the cash came from and went

Precigen: sources (+) and uses (−) of cash, Q3 2026Precigen: sources (+) and uses (−) of cash, Q3 2026Other investing−$13.5MOperating cash flow$11.9MCash drawn (+) / kept (−)$1.4MShares issued$944KCapital spending−$435KTaxes on employees’ shares−$211KExchange rates−$12K
Precigen: sources (+) and uses (−) of cash, TTM to Q3 2026Precigen: sources (+) and uses (−) of cash, TTM to Q3 2026Other investing$74.7MOperating cash flow−$73.2MShares issued$2.7MTaxes on employees’ shares−$1.7MCapital spending−$1.1MNet borrowing (+) / repaid (−)−$654KCash drawn (+) / kept (−)−$637KExchange rates$6K

From profit to cash

Precigen: net income to operating cash flow, Q3 2026Precigen: net income to operating cash flow, Q3 2026Net income$35.8MDepreciation & amortization$1.1MStock-based pay$3.8MReceivables−$24.6MInventory−$2.7MPayables$1.1MAccrued liabilities−$1.8MEmployee-related liabilities$1.4MDeferred revenue−$110KPrepaid and other assets−$2.3MOther liabilities−$29KOperating cash flow$11.9M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q3 2026$11.9M−$435K—$944K$1.4M$11.4M
Q2 2026−$17.8M−$392K—$1.3M−$8.8M−$18.2M
Q1 2026−$43.8M−$258K—$255K$22.8M−$44.1M
Q4 2025−$23.5M−$18K−$654K$140K−$15.9M−$23.5M
Q3 2025−$29.1M−$389K—$839K−$562K−$29.5M
Q2 2025−$19.0M−$966K—$73K−$7.7M−$19.9M
Q1 2025−$16.3M−$622K—−$205K$23.5M−$16.9M
Q4 2024−$8.2M−$1.0M—−$596K−$4.8M−$9.3M

Precigen: income statement and cash flow

Precigen, Q3 2026: revenue $74.1M (25× year over year), operating margin 52.1%. The chart follows the revenue to costs, profit and cash.

Precigen: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.